4Simon C, Garcia Velasco JJ, Valbuera D, et al. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen[J]. Fertil Steril, 1998,70(2) : 234-239.
5Levy DP, Navarro JM, Schattman GL, et al. The role of LH in ovarian stimulation, exogenous LH: let's design the future[J]. Hum Repod,2000,t5(11):2258-2265.
6Nestler JE, Stovall D, Akhter N, et al. Strategies for the use of insulin-senstitizing drugs to treat infertility in women with polyeystie ovary syndrome [J ]. Fertil Steril, 2002, 77 ( 2 ) : 209-215.
7The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome [J]. Hum Reprod,2004,19(1) :41-47.
8Claudio AB,Dehorah AM. Superovulation with human menopausal gonadotrophin is assoeiated with endometrial glandstromadyssynehrony[J]. Fertil Steril, 1994, 61 (4):700- 704.
9Richard JP, Mark VS,Rogerio AL. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis[J]. Fertil Steril, 1997, 87(2)..321-325.
10Cincotta AH, Meier AH. Bromocriptine inshibits in vivo free fatty acid oxidation and hepatic glacose output in seasonally obese hansters [J]. Metabolism,1995,44(10):1349-1355.
